ATAI Life Stock Financials

ATAI
 Stock
  

USD 3.34  0.21  5.92%   

Please use analysis of ATAI Life Sciences fundamentals to determine if markets are correctly pricing the company. We were able to analyze thirty-six available financial indicators for ATAI Life, which can be compared to its peers in the sector. To ensure the equity is not overpriced, please confirm all ATAI Life Sciences financials, including its current valuation, price to book, cash and equivalents, as well as the relationship between the shares owned by institutions and gross profit . Given that ATAI Life Sciences has a price to earning of 0.30 X, we suggest you to validate ATAI Life latest market performance to make sure the company can sustain itself in the future. Use ATAI Life to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of ATAI Life to be traded at $3.17 in 90 days.
  
With this module, you can analyze ATAI Life financials for your investing period. You should be able to track the changes in ATAI Life individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

ATAI Life Most Recent Estimates

Quarterly Earnings Growth YOY
(0.97) 
EPS Estimate Next Quarter
(0.23) 
Diluted Eps
(1.40) 
EPS Estimate Current Year
(0.91) 
EPS Estimate Next Year
(1.03) 
EPS Estimate Current Quarter
(0.23) 
Understanding current and past ATAI Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ATAI Life's financial statements are interrelated, with each one affecting the others. For example, an increase in ATAI Life's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 27
ATAI Life Sciences has less than 27 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for ATAI Life stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in ATAI Life's official financial statements usually reflect ATAI Life's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ATAI Life Sciences. For example, before you start analyzing numbers published by ATAI Life accountants, it's critical to develop an understanding of what ATAI Life's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of ATAI Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ATAI Life's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ATAI Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ATAI Life Sciences. Please utilize our Beneish M Score to check the likelihood of ATAI Life's management to manipulate its earnings.

ATAI Life Company Summary

ATAI Life competes with Ametek, Euro Tech, Mettler-Toledo International, Etsy, and Anheuser-Busch InBev. Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.
Specialization
Technology, High Precision And Instrumentation Products
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS00211V1061
Business AddressKrausenstrasse 9-10, Berlin,
SectorHealthcare
IndustryBiotechnology
BenchmarkNYSE Composite
Websitewww.atai.life
Phone49 89 2153 9035
CurrencyUSD - US Dollar
You should never invest in ATAI Life without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ATAI Life Stock, because this is throwing your money away. Analyzing the key information contained in ATAI Life's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

ATAI Life Key Financial Ratios

Generally speaking, ATAI Life's financial ratios allow both analysts and investors to convert raw data from ATAI Life's financial statements into concise, actionable information that can be used to evaluate the performance of ATAI Life over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ATAI Life Sciences reports annually and quarterly.

ATAI Life Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ATAI Life's current stock value. Our valuation model uses many indicators to compare ATAI Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ATAI Life competition to find correlations between indicators driving ATAI Life's intrinsic value. More Info.
ATAI Life Sciences is number one stock in market capitalization category among related companies. It is number one stock in price to book category among related companies . The ratio of Market Capitalization to Price to Book for ATAI Life Sciences is about  325,119,399 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ATAI Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ATAI Life's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ATAI Life's earnings, one of the primary drivers of an investment's value.

ATAI Life Sciences Systematic Risk

ATAI Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ATAI Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on ATAI Life Sciences correlated with the market. If Beta is less than 0 ATAI Life generally moves in the opposite direction as compared to the market. If ATAI Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ATAI Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ATAI Life is generally in the same direction as the market. If Beta > 1 ATAI Life moves generally in the same direction as, but more than the movement of the benchmark.
.

About ATAI Life Financials

What exactly are ATAI Life Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include ATAI Life's income statement, its balance sheet, and the statement of cash flows. Potential ATAI Life investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ATAI Life investors may use each financial statement separately, they are all related. The changes in ATAI Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ATAI Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as ATAI Life is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of ATAI Life has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

ATAI Life December 4, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of ATAI Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ATAI Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of ATAI Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing ATAI Life Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ATAI Life's daily price indicators and compare them against related drivers.
Information Ratio(0.08)
Maximum Drawdown21.68
Value At Risk(6.76)
Potential Upside8.56
Please continue to Trending Equities. Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for ATAI Life Stock analysis

When running ATAI Life Sciences price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.97) 
Market Capitalization
588.9 M
Quarterly Revenue Growth YOY
(0.91) 
Return On Assets
(0.22) 
Return On Equity
(0.54) 
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI Life that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine ATAI Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.